Navigation Links
Zebrafish offer clues to treatments for motor neurone disease
Date:4/29/2009

Tiny zebrafish could hold the key to stem cell treatments for motor neurone disease.

Scientists at the University of Edinburgh have found that these fish are able to produce motor neurones cells that control all muscle activity such as speaking, walking and breathing in humans when they repair damage to their spinal cords.

Researchers are now screening small molecules with a view to finding drugs that could kick-start the process of motor neurone regeneration in zebrafish, with a view to translating their findings into treatments for humans.

The discovery could help patients with motor neurone disease, in which the motor neurone cells die and are not replaced. This disease can cause paralysis and severe breathing difficulties and is an ultimately fatal condition for which no cure exists.

Dr Catherina Becker, from the University of Edinburgh's Centre for Neuroregeneration and Euan MacDonald Centre for Motor Neurone Disease Research, said: "Understanding how zebrafish can regenerate large numbers of motor neurones after damage to the spinal cord and how these motor neurones are produced by natural stem cells could help in finding treatments for Motor Neurone Disease.

"This could take the form of improving methods of generating motor neurones in the laboratory that could be transplanted or finding drugs which could help patients renew their motor neurone supply."

The tropical zebrafish, which are transparent and around 3 cm long, produce the motor neurones from progenitor cells found in the spinal cord that are able to turn into certain types of cells.

As well as looking at stimulating the production of motor neurones, scientists are working on ways to ensure that these cells are able to function by sending messages from the brain to the spine and then on to muscles. The research could also have implications for treating spinal cord injuries following accidents.

The research team is the first to benefit from the Edinburgh BioQuarter commercialisation initiative, funded by the University of Edinburgh and Scottish Enterprise, to assist translating research into therapies. Researchers have also received a joint grant from the Robert Packard Center in Baltimore and Euan MacDonald Centre in Edinburgh, which specialise in research into amyotrophic lateral sclerosis (ALS), the most common form of Motor Neurone Disease.


'/>"/>

Contact: Tara Womersley
tara.womersley@ed.ac.uk
01-316-509-836
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. Microbiotic technology developed for microinjection of zebrafish embryos
2. NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
3. Transparent zebrafish help researchers track breast cancer
4. Phylonix granted broad European patent for transplanting human cells into zebrafish
5. Zebrafish provide useful screening tool for genes, drugs that protect against hearing loss
6. Zebrafish may help solve ringing in vets ears
7. Secret to Treating Tinnitus in Vets May Be Unlocked in Zebrafish
8. Zebrafish enable scientists to study the migration of neurons that enable sexual maturity
9. Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race
10. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
11. Health care incentive model offers collaborative approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology: